PHGEBiomX Inc.

NYSE biomx.com


$ 0.97 $ -0.01 (-0.77 %)    

Monday, 16-Sep-2024 15:59:35 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 0.9851
$ 0.98
-- x --
-- x --
$ 0.96 - $ 0.98
$ 0.94 - $ 8.55
29,506
na
6.88M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-04-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-24-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-26-2020 12-31-2019 10-K
20 10-16-2019 09-30-2019 10-Q
21 08-21-2019 06-30-2019 10-K
22 05-10-2019 03-31-2019 10-Q
23 02-06-2019 12-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biomx-to-present-phase-1b2a-clinical-trial-data-for-bx004-at-the-ers-congress-2024

BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and enginee...

 hc-wainwright--co-reiterates-buy-on-biomx-maintains-2-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BiomX (AMEX:PHGE) with a Buy and maintains $2 price target.

 biomx-q2-gaap-eps-007-up-from-012-yoy

BiomX (AMEX:PHGE) reported quarterly losses of $(0.07) per share. This is a 41.67 percent increase over losses of $(0.12) per s...

 laidlaw--co-initiates-coverage-on-biomx-with-buy-rating-announces-price-target-of-25

Laidlaw & Co. analyst Yale Jen initiates coverage on BiomX (AMEX:PHGE) with a Buy rating and announces Price Target of $...

 hc-wainwright--co-reiterates-buy-on-biomx-maintains-2-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BiomX (AMEX:PHGE) with a Buy and maintains $2 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION